AMO-02-MD-2-004
Showing 1 - 25 of >10,000
Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib)
Enrolling by invitation
- Congenital Myotonic Dystrophy
-
Little Rock, Arkansas
- +10 more
Nov 15, 2021
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)
Active, not recruiting
- VHL - Von Hippel-Lindau Syndrome
- +5 more
-
Bethesda, Maryland
- +10 more
Aug 16, 2022
Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)
Recruiting
- Hematological Malignancies
- Pembrolizumab/vibostolimab coformuation
-
Duarte, California
- +64 more
Jan 27, 2023
Nonalcoholic Steatohepatitis Trial in Fort Sam Houston (GR-MD-02, Placebo)
Completed
- Nonalcoholic Steatohepatitis
- GR-MD-02
- Placebo
-
Fort Sam Houston, TexasBrooke Army Medical Center
Oct 6, 2020
Atopic Dermatitis Trial in Worldwide (Placebo, ASLAN004)
Recruiting
- Atopic Dermatitis
- Placebo
- ASLAN004
-
Encino, California
- +44 more
Jul 28, 2022
Melanoma Trial in Belgium, Spain (ECI-006)
Terminated
- Melanoma
- ECI-006
-
Antwerpen, Belgium
- +8 more
Jun 16, 2021
Autism Spectrum Disorder Trial in Staten Island (ML-004 (IR)/(ER) tablet)
Recruiting
- Autism Spectrum Disorder
- ML-004 (IR)/(ER) tablet
-
Staten Island, New YorkRichmond Behavioral Associates
Jun 1, 2023
Glioma Trial in Dallas, Houston, San Antonio (Rhenium Liposome Treatment)
Recruiting
- Glioma
- Rhenium Liposome Treatment
-
Dallas, Texas
- +2 more
Nov 3, 2021
Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)
Recruiting
- Melanoma
- Pembrolizumab
- +4 more
-
Los Angeles, California
- +34 more
Jan 25, 2023
Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)
Active, not recruiting
- Advanced Solid Tumors
- AMG 994
- AMG 404
-
Duarte, California
- +16 more
Nov 16, 2022
Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)
Completed
- Metastatic Colorectal Cancer
-
Stockton, California
- +151 more
Sep 8, 2022
Relapsed or Refractory DLBCL Trial in Worldwide (MK-2140 (zilovertamab vedotin))
Recruiting
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- MK-2140 (zilovertamab vedotin)
-
Orange, California
- +38 more
Aug 12, 2022
Recent-Onset Type 1 Diabetes Extension Study Evaluating
Enrolling by invitation
- Type 1 Diabetes Mellitus
- Teplizumab
- Placebo
-
San Diego, California
- +41 more
Jan 31, 2023
ALS, FTD Trial in Utrecht (WVE-004)
Enrolling by invitation
- ALS
- FTD
-
Utrecht, NetherlandsUniversitair Medisch Centrum Utrecht
Jan 4, 2023
Myopia, Astigmatism Trial in Palo Alto (Wavefront-guided LASIK - Allegretto, Wavefront-guided LASIK - AMO)
Completed
- Myopia
- Astigmatism
- Wavefront-guided LASIK - Allegretto
- Wavefront-guided LASIK - AMO
-
Palo Alto, CaliforniaByers Eye Institute at Stanford
Apr 3, 2022
Spondylitis, Ankylosing Trial in Worldwide (CC-99677, Placebo)
Active, not recruiting
- Spondylitis, Ankylosing
- CC-99677
- Placebo
-
Flagstaff, Arizona
- +139 more
Dec 9, 2022
Spinal Muscular Atrophy (SMA) Trial in Ekaterinburg, Moscow, Saint Petersburg (ANB-004, dose 1, ANB-004, dose 2, ANB-004, dose
Recruiting
- Spinal Muscular Atrophy (SMA)
- ANB-004, dose 1
- +2 more
-
Ekaterinburg, Russian Federation
- +5 more
Feb 17, 2023